social media, rx promotion, & fda, part2

11
Social Media, Rx Promo1on, & FDA Results of a survey of readers & followers of Pharma Marketing News, Pharma Marketing Blog, and @pharmaguy John Mack Publisher, Pharma marketing News & Pharma Marketing Blog @pharmaguy on Twitter [email protected]

Upload: pharmaguy

Post on 27-Nov-2014

2.487 views

Category:

Health & Medicine


0 download

DESCRIPTION

Presentation made by John Mack at November 12-13, 2009 FDA public hearing on regulating pharmaceutical promotion on Internet and social networks. Covers issue:Adverse Event Repor1ng

TRANSCRIPT

Page 1: Social Media, Rx Promotion, & FDA, Part2

SocialMedia,RxPromo1on,&FDA

Results of a survey ofreaders & followers ofPharma Marketing News,Pharma Marketing Blog,and @pharmaguy

John MackPublisher, Pharma marketing News &Pharma Marketing Blog@pharmaguy on Twitter

[email protected]

Page 2: Social Media, Rx Promotion, & FDA, Part2

2

SurveyOverview

Online—started20September2009

IncludesAll19ques1onsforwhichFDAseeksanswers

Talliesvotesonspecificanswers/solu1ons

Plus575comments

354Respondentsasof1November2009

126Blogreaders

101PMNsubscribers

64TwiUerfollowers

45Websitevisitors

Page 3: Social Media, Rx Promotion, & FDA, Part2

3

Part2

AdverseEventRepor1ng

Page 4: Social Media, Rx Promotion, & FDA, Part2

4

AdverseEvents:SummaryofFindings

Vastmajorityof“AdverseExperiences”reportedonsocialmediasitesdoNOTmeettherequirementsforAErepor1ng

Greatmajorityofrespondents(upto87%)agree*

Althoughtherearemonitoringtoolsavailable,theresourcesrequiredtomonitorallsocialmediasitesforadverseeventsarenotjus1fiable

Consequently,fewcompanieshavestandardopera1ngproceduresforprocessingadverseeventinforma1onfromsocialmediasites

However,pharmacompaniescanhelpconsumersreportadverseeventsdirectlytotheFDAusingsocialmediatoolssuchaswidgetsplacedondrug.comWebsites(seeslide#9).

*Seeslide#5

Page 5: Social Media, Rx Promotion, & FDA, Part2

5

SocialMediaAEChallenges

What challenges are presented in handling adverse event information from these sources?

Theamountofinforma1onfromthesesourcesispoten1allytoovasttobeprocessedeconomically(lackofresources)Findingadverseeventinforma1onfromthesesourcesislikefindinganeedleinahaystack(toodaun1ng)

Theinforma1onisusuallyincompleteanddoesnotmeettherequirementsforsubmigngameaningfulAER(notac1onable)

Therearemanypoten1alissuesthatwon'tfullybeknownun1ltheprac1ceofmonitoringsocialmediaforAEsismoreprevalent(unknownissues)

Adverse Event Reporting

Page 6: Social Media, Rx Promotion, & FDA, Part2

6

SocialMediaAEUncertain1es

What uncertainties are there regarding what should be reported from these sources to meet FDAadverse event reporting obligations?

Uncertaintyregardingthetrueiden1tyofthereporter(anonymoussource)

Uncertaintyregardingthetrueiden1tyofthepa1ent(nopa1entnamed)

Uncertaintyregardingtheiden1tyofthedrug(eg,reporterrefersto"sleeppill"ratherthanbrandnameofdrug)

Uncertaintyregardingtheseriousnessoftheeventreported

Adverse Event Reporting

Page 7: Social Media, Rx Promotion, & FDA, Part2

7

MonitoringAEsonSocialMediaSites

How are entities with postmarketing reporting responsibilities and other stakeholders using theInternet and social media tools with regard to monitoring adverse event information about theirproducts?

Useofautomatedkeywordsearchesofselectedsocialmediasitesbyspecializedagenciesand/orprofessionals

IntermiUentsearchesofselectedsocialmediasitesperformedbycompanypersonneloragents

IntermiUentsearchesofSEARCHENGINESperformedbycompanypersonneloragents

Rou1neandautomatedkeywordsearchesofTWITTER(eg,performedbySocialOomphorotherservices)

Useofsocialmediamonitoringtoolsthatdonotincludekeywords

Adverse Event Reporting

Page 8: Social Media, Rx Promotion, & FDA, Part2

8

ProcessingSocialMediaAEInforma1on

How is adverse event information from these sources being received, reviewed, and processed?

Specialgroupwithinthecompanyisresponsibleforreceiving,reviewing,andprocessingAEs

ReceivingandprocessingAEsisoutsourcedtoaspecializedagency;reviewishandledin‐housetodeterminewhichAEsneedtobereportedasrequiredbylaw

WehavenoSOP(StandardOpera1ngProcedure)forreceiving,reviewing,andprocessingAEsfromthesesources

Adverse Event Reporting

Page 9: Social Media, Rx Promotion, & FDA, Part2

9

AERepor1ngSafeHarborWidget“One‐Click”AccesstoFDAand/orPharmacoAERepor=ngSystem

Pharmaceu1calcompaniesthatpostapprovedwidgetsontheirdrug.comWebsitesshouldbeallowedtomonitor3rd‐partysocialmediasiteswithouttheneedtoreportanypoten1aladverseeventstheymaycomeacross.

Page 10: Social Media, Rx Promotion, & FDA, Part2

OnSaleOutsideorOnline

Hoping for HelpfulGuidelines, but NotExpecting Any

Page 11: Social Media, Rx Promotion, & FDA, Part2

11

ContactInforma1on

John Mack

Follow me on Twitter:http://twitter.com/pharmaguy

Facebook page:http://www.facebook.com/pharmaguy

www.news.pharma-mkting.comwww.pharmamkting.blogspot.com

[email protected]

215-504-4164215-504-5739 (Fax)